InhaleRx Limited (ASX:IRX)
Australia · Delayed Price · Currency is AUD 0.0250
0.00 (0.00%)
Jan 30, 2026, 11:09 AM AEST
InhaleRx Market Cap
InhaleRx has a market cap or net worth of 6.16 million as of January 30, 2026. Its market cap has decreased by -7.31% in one year.
Market Cap
6.16M
Enterprise Value
6.01M
Revenue
833.90K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
Market Cap Chart
Since January 11, 2017, InhaleRx's market cap has decreased from 29.98M to 6.16M, a decrease of -79.46%. That is a compound annual growth rate of -16.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 6.16M | 7.17% |
| Dec 29, 2025 | 5.74M | -23.11% |
| Dec 30, 2024 | 7.47M | 35.76% |
| Dec 18, 2023 | 5.50M | -51.02% |
| Dec 29, 2022 | 11.24M | -25.89% |
| Dec 30, 2021 | 15.16M | 46.10% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AdAlta | 11.48M |
| Immuron | 11.39M |
| Patrys | 11.24M |
| Chimeric Therapeutics | 11.05M |
| Bio-Gene Technology | 9.46M |
| Invex Therapeutics | 9.02M |
| Zelira Therapeutics | 7.73M |
| Vectus Biosystems | 7.48M |